Bolt Biotherapeutics Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| SOFINNOVA INVESTMENTS, INC. | 08/14/2026 | 137.72 K | $530.23 K | 0.00% | 8.15% |
| RENAISSANCE TECHNOLOGIES LLC | 08/13/2026 | 98.63 K | $379.71 K | 27.71% | 5.83% |
| VIVO CAPITAL, LLC | 08/14/2026 | 72.41 K | $278.79 K | 0.00% | 4.28% |
| CITADEL ADVISORS LLC | 09/02/2026 | 56.90 K | $219.08 K | 462.89% | 3.37% |
| T3 COMPANIES, LLC | 07/27/2026 | 38.00 K | $146.30 K | 0.00% | 2.25% |
| BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY | 08/12/2026 | 35.98 K | $138.51 K | 0.00% | 2.13% |
| PFIZER INC | 08/13/2026 | 31.31 K | $133.83 K | 0.00% | 1.85% |
| LYNX1 CAPITAL MANAGEMENT LP | 08/13/2026 | 30.80 K | $118.58 K | 0.00% | 1.82% |
| NANO CAP NEW MILLENNIUM GROWTH FUND L P | 08/14/2026 | 27.50 K | $105.88 K | 0.00% | 1.63% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/12/2026 | 19.12 K | $73.62 K | -33.59% | 1.13% |
| SHAY CAPITAL LLC | 08/14/2026 | 15.44 K | $59.44 K | 3.58% | 0.91% |
| BLACKROCK, INC. | 08/07/2026 | 9.71 K | $37.39 K | 0.00% | 0.57% |
| VANGUARD CAPITAL MANAGEMENT LLC | 08/13/2026 | 7.06 K | $27.18 K | 0.00% | 0.42% |
| NAN FUNG GROUP HOLDINGS LTD | 08/13/2026 | 5.00 K | $19.25 K | -82.91% | 0.30% |
| MORGAN STANLEY | 08/13/2026 | 3.15 K | $12.11 K | -1.38% | 0.19% |
| VANGUARD FIDUCIARY TRUST CO | 08/13/2026 | 3.10 K | $11.92 K | 0.00% | 0.18% |
| NEWEDGE ADVISORS, LLC | 08/12/2026 | 2.53 K | $9.74 K | 100.00% | 0.15% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 08/11/2026 | 1.71 K | $6.58 K | 56.45% | 0.10% |
| MERCER GLOBAL ADVISORS INC /ADV | 08/11/2026 | 292 | $1.12 K | 100.00% | 0.02% |
| UBS GROUP AG | 08/13/2026 | 255 | $982 | -67.60% | 0.02% |
| SBI SECURITIES CO., LTD. | 07/23/2026 | 130 | $501 | 1,200.00% | 0.01% |
| JPMORGAN CHASE & CO | 08/12/2026 | 42 | $165 | 0.00% | 0.00% |
| CITIGROUP INC | 08/03/2026 | 41 | $158 | 100.00% | 0.00% |
| BARCLAYS PLC | 08/14/2026 | 6 | $23 | 0.00% | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 08/14/2026 | 0 | $0 | -100.00% | 0.00% |
| VANGUARD GLOBAL ADVISERS, LLC | 08/13/2026 | 0 | $0 | -100.00% | 0.00% |
| PIVOTAL BIOVENTURE PARTNERS INVESTMENT ADVISOR LLC | 08/13/2026 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Bolt Biotherapeutics Inc institutional Ownership - FAQ's
During the previous two years, 34 institutional investors and hedge funds held shares of Bolt Biotherapeutics Inc. The most heavily invested institutionals were:
Sofinnova Investments, Inc.: 137,721
RENAISSANCE TECHNOLOGIES LLC: 98,625
Vivo Capital, LLC: 72,414
CITADEL ADVISORS LLC: 56,903
T3 Companies, LLC: 38,000
Board of Trustees of The Leland Stanford Junior University: 35,977
35.30% of Bolt Biotherapeutics Inc stock is owned by institutional investors.
Institutional investors have bought a total of 1.50 M shares in the last 24 months. This purchase volume represents approximately $6.17 M in transactions.